The results showed that prostate epithelial cells express relatively high levels of LC3 and Beclin‐1 after 5‐ARI treatment in surgical BPH 5‐ARI+ compared with surgical BPH 5‐ARI‐ (Figure 2B, Table S4). The gene discussed is MAP1LC3A; the disease is benign prostatic hyperplasia.